Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients

被引:87
|
作者
Govoni, Marcello [1 ]
Bombardieri, Stefano [2 ]
Bortoluzzi, Alessandra [1 ]
Caniatti, Luisa [3 ]
Casu, Cinzia [4 ]
Conti, Fabrizio [5 ]
de Vita, Salvatore [6 ]
Doria, Andrea [7 ]
Farina, Ilaria [1 ]
Ferraccioli, Gianfranco [8 ]
Gremese, Elisa [8 ]
Mansutti, Elisa
Mosca, Marta [2 ]
Padovan, Melissa
Piga, Matteo [9 ]
Tincani, Angela [4 ]
Tola, Maria Rosaria
Tomietto, Paola
Taglietti, Marco
Trotta, Francesco [1 ]
Valesini, Guido [5 ]
Zen, Margherita [7 ]
Mathieu, Alessandro [9 ]
机构
[1] Univ Ferrara, Dept Clin & Expt Med, Rheumatol Sect, I-44121 Ferrara, Italy
[2] Univ Pisa, Dept Internal Med, Rheumatol Unit, Pisa, Italy
[3] St Anna Hosp, Dept Neurosci, Ferrara, Italy
[4] Spedali Civili & Univ Brescia, Rheumatol & Clin Immunol Unit, Brescia, Italy
[5] Univ Roma La Sapienza, Dept Internal Med, Rome, Italy
[6] Univ Udine, Rheumatol Clin, Azienda Osped Univ S Maria Misericordia, Dept Med Subspecialties, I-33100 Udine, Italy
[7] Univ Padua, Div Rheumatol, Dept Clin & Expt Med, Padua, Italy
[8] Univ Cattolica Sacro Cuore, Div Rheumatol & Internal Med, Dept Internal Med & Med Subspecialties, CIC, I-00168 Rome, Italy
[9] Univ & AOU Cagliari, Rheumatol Unit, Cagliari, Italy
关键词
systemic lupus erythematosus; neuropsychiatric lupus; neurological involvement; anti-phospholipid antibodies; anti-phospholipid syndrome; cerebrovascular disease; CLASSIFICATION CRITERIA; CLINICAL-FEATURES; SJOGRENS-SYNDROME; DISEASE-ACTIVITY; COHORT; DAMAGE; INVOLVEMENT; MANIFESTATIONS; PREDICTORS; COLLEGE;
D O I
10.1093/rheumatology/ker310
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To analyse risk factors and comorbidities potentially associated with CNS involvement in a large cohort of Italian patients affected by SLE. Methods. A number of generic (not strictly SLE related) and specific (disease related) risk factors to which all patients have been exposed in the span of 5 years before the first neuropsychiatric (NP) event or before the last available observation were checked for and their distribution was analysed in 959 SLE patients with and without NP involvement; all the first NP events that occurred in a time frame of 10 years were recorded and categorized as SLE related or SLE unrelated. Results. Three hundred and twenty-six SLE patients with and 633 SLE patients without NP manifestations were included in the study. A total of 469 NP events were recorded. Headache (26.1%), cerebrovascular events (22.7%), mood disorders (8.9%), seizures (14.4%) and cognitive dysfunctions (9.5%) were the most frequent SLE-related NP events. More risk factors [mean 4.52 (2.44) vs 3.73 (2.01); P<0.0001] were observed in patients with than without NP involvement. Overall, aPLs, LA and APS were factors more strongly associated with NP involvement. Conclusions. In SLE, NP involvement and aPLs were confirmed as closely related. Furthermore, other modifiable generic risk factors, such as hypertension, carotid vasculopathy and dyslipidaemia, appeared to be related to the occurrence of cerebral vascular accident (CVA) and cognitive dysfunctions, suggesting the need for a more intensive preventive strategy to optimize the management of NP lupus.
引用
收藏
页码:157 / 168
页数:12
相关论文
共 50 条
  • [1] The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional study
    Yan Liang
    Rui-Xue Leng
    Hai-Feng Pan
    Dong-Qing Ye
    Rheumatology International, 2017, 37 : 305 - 311
  • [2] The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional study
    Liang, Yan
    Leng, Rui-Xue
    Pan, Hai-Feng
    Ye, Dong-Qing
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (02) : 305 - 311
  • [3] Factors associated with intimacy in female Taiwanese patients with systemic lupus erythematosus: a cross-sectional study
    Hsu, Chia-Wen
    Hsu, Bao-Bao
    Koo, Malcolm
    Lu, Ming-Chi
    BMJ OPEN, 2022, 12 (04):
  • [4] Assessment of drug-drug interactions and their associated risk factors in patients with systemic lupus erythematosus: A cross-sectional study
    Sah, Sujit Kumar
    Ramaswamy, Subramanian
    Madhan, Ramesh
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 173 - 173
  • [5] Latent Tuberculosis Infection and Associated Factors in Patients with Systemic Lupus Erythematosus: a Multicenter, Cross-Sectional Study
    Zhang, Lifan
    Ma, Yanan
    Jiang, Nan
    Zou, Xiaoqing
    Zhang, Yueqiu
    Zhang, Fengchun
    Zeng, Xiaofeng
    Zhao, Yan
    Liu, Shengyun
    Zuo, Xiaoxia
    Wu, Huaxiang
    Wu, Lijun
    Li, Hongbin
    Zhang, Zhiyi
    Chen, Sheng
    Zhu, Ping
    Zhang, Miaojia
    Qi, Wencheng
    Liu, Yi
    Liu, Huaxiang
    Shi, Xiaochun
    Liu, Xiaoqing
    MICROBIOLOGY SPECTRUM, 2023, 11 (03):
  • [6] Factors associated with the use of complementary therapies in Taiwanese patients with systemic lupus erythematosus: a cross-sectional study
    Ming-Chi Lu
    Hui-Chin Lo
    Hsiu-Hua Chang
    Chia-Wen Hsu
    Malcolm Koo
    BMC Complementary Medicine and Therapies, 21
  • [7] Factors associated with the use of complementary therapies in Taiwanese patients with systemic lupus erythematosus: a cross-sectional study
    Lu, Ming-Chi
    Lo, Hui-Chin
    Chang, Hsiu-Hua
    Hsu, Chia-Wen
    Koo, Malcolm
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2021, 21 (01)
  • [8] Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case–control study from a single center
    Melissa Padovan
    Gabriella Castellino
    Alessandra Bortoluzzi
    Luisa Caniatti
    Francesco Trotta
    Marcello Govoni
    Rheumatology International, 2012, 32 : 129 - 135
  • [9] Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case-control study from a single center
    Padovan, Melissa
    Castellino, Gabriella
    Bortoluzzi, Alessandra
    Caniatti, Luisa
    Trotta, Francesco
    Govoni, Marcello
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (01) : 129 - 135
  • [10] Polypharmacy prevalence and associated factors in patients with systemic lupus erythematosus: A single-centre, cross-sectional study
    Miyake, Hirofumi
    Sada, Ryuichi Minoda
    Akebo, Hiroyuki
    Tsugihashi, Yukio
    Hatta, Kazuhiro
    MODERN RHEUMATOLOGY, 2023, 34 (01) : 106 - 112